Clinical Trials in Minneapolis

Showing 10761-10780 of 14,456 trials

ESSENTIAL Trial™ Sham Cross-over

NCT02279420

This is a multicenter, un-blinded, open label, pivotal supplemental study to G130163 intended to evaluate the safety and efficacy of treating previous sham subjects in the Essential pivotal trial (IDE#G130163) with the active treatment (the placement of g-Cath EZ suture anchors along with diet and exercise). Compliant sham subjects (those who attended all primary IDE follow-up visits AND who continue to meet eligibility criteria as described in this protocol) will be offered this active treatment after their 12 month unblinding visit in the Essential pivotal trial.

Obesity

USGI Medical73 participantsStarted Jan 2015

Scottsdale, Arizona, United States • Miami, Florida, United States • Dalton, Georgia, United States +8 more locations

TERMINATEDPhase 2< 1 mile

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

NCT00515099

Antithymocyte globulin (e.g., Thymoglobulin®) is an antibody preparation that is commonly used to treat and prevent organ transplant rejection. The START trial aims to determine whether antithymocyte globulin (ATG) treatment can halt the progression of newly diagnosed type 1 diabetes when given within 12 weeks of disease diagnosis.

New-onset Type 1 Diabetes Mellitus

National Institute of Allergy and Infectious Diseases (NIAID)58 participantsStarted Aug 2007

Los Angeles, California, United States • Oakland, California, United States • San Diego, California, United States +6 more locations

ESSENTIAL Trial™ Sham Cross-over

Study of Antithymocyte Globulin for Treatment of New-onset T1DM

Find Trials by Condition in Minneapolis

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes

Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)

Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

The Effects of D-cycloserine on Stimulus Generalization of Conditioned Fear Healthy Controls.

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

Phase II Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide in Patients With Dumping Syndrome

Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Ovarian Cancer Vaccine for Patients in Remission

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

Dose-Escalation Study of GSK2126458